- Home
- DRUG vs INGN Comparison
DRUG vs INGN Comparison
Compare DRUG & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- INGN
- Stock Information
- Founded
- DRUG 2019
- INGN 2001
- Country
- DRUG United States
- INGN United States
- Employees
- DRUG N/A
- INGN N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- INGN Industrial Specialties
- Sector
- DRUG Health Care
- INGN Health Care
- Exchange
- DRUG Nasdaq
- INGN Nasdaq
- Market Cap
- DRUG 199.7M
- INGN 219.3M
- IPO Year
- DRUG N/A
- INGN 2014
- Fundamental
- Price
- DRUG $48.75
- INGN $8.54
- Analyst Decision
- DRUG Strong Buy
- INGN Strong Buy
- Analyst Count
- DRUG 9
- INGN 3
- Target Price
- DRUG $81.67
- INGN $11.00
- AVG Volume (30 Days)
- DRUG 72.8K
- INGN 190.3K
- Earning Date
- DRUG 08-11-2025
- INGN 11-06-2025
- Dividend Yield
- DRUG N/A
- INGN N/A
- EPS Growth
- DRUG N/A
- INGN N/A
- EPS
- DRUG N/A
- INGN N/A
- Revenue
- DRUG N/A
- INGN $343,472,000.00
- Revenue This Year
- DRUG N/A
- INGN $7.68
- Revenue Next Year
- DRUG N/A
- INGN $6.47
- P/E Ratio
- DRUG N/A
- INGN N/A
- Revenue Growth
- DRUG N/A
- INGN 5.15
- 52 Week Low
- DRUG $0.94
- INGN $5.70
- 52 Week High
- DRUG $79.02
- INGN $12.91
- Technical
- Relative Strength Index (RSI)
- DRUG 66.11
- INGN 67.30
- Support Level
- DRUG $39.70
- INGN $8.21
- Resistance Level
- DRUG $46.44
- INGN $8.65
- Average True Range (ATR)
- DRUG 3.25
- INGN 0.33
- MACD
- DRUG 0.20
- INGN 0.03
- Stochastic Oscillator
- DRUG 93.56
- INGN 89.91
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.